These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9786361)

  • 21. Safety monitoring of drugs granted exclusivity under the Best Pharmaceuticals for Children Act: what the FDA has learned.
    Mathis LL; Iyasu S
    Clin Pharmacol Ther; 2007 Aug; 82(2):133-4. PubMed ID: 17632537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of FDA reform.
    Trunzo J
    Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FDA modernization act of 1997: guidance on medical device tracking; availability--FDA. Notice.
    Fed Regist; 1998 Mar; 63(42):10640-1. PubMed ID: 10177505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vioxx's history and the need for better procedures and better testing.
    Gilhooley M
    Seton Hall Law Rev; 2007; 37(4):941-68. PubMed ID: 18363218
    [No Abstract]   [Full Text] [Related]  

  • 25. List of drug products that have been withdrawn or removed from the market for reasons of safety or effectiveness--FDA. Proposed rule.
    Fed Regist; 1998 Oct; 63(195):54082-9. PubMed ID: 10185826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FDA reporting program is key to safety information.
    Young D
    Am J Health Syst Pharm; 2002 Dec; 59(23):2279, 2284, 2289. PubMed ID: 12489365
    [No Abstract]   [Full Text] [Related]  

  • 27. Applications for Food and Drug Administration application approval to market a new drug; revision of postmarketing reporting requirements. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Oct; 72(201):58993-9000. PubMed ID: 17966558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The case for preemption of prescription drug failure-to-warn claims.
    Kim CH
    Food Drug Law J; 2007; 62(2):399-422. PubMed ID: 17632969
    [No Abstract]   [Full Text] [Related]  

  • 29. Pin the tail on the other donkey: allocating and avoiding injury losses after drug or device approval.
    O'Reilly JT
    Food Drug Law J; 2007; 62(3):559-72. PubMed ID: 17915397
    [No Abstract]   [Full Text] [Related]  

  • 30. Medical-device safety and the FDA.
    Schultz DG
    N Engl J Med; 2008 Jul; 359(1):88-9; author reply 89. PubMed ID: 18596278
    [No Abstract]   [Full Text] [Related]  

  • 31. FDA alerts asthmatics to drug safety risk.
    Ellis C
    Nat Rev Drug Discov; 2003 Oct; 2(10):765. PubMed ID: 14577428
    [No Abstract]   [Full Text] [Related]  

  • 32. FDA works to reduce preventable medical device injuries.
    Rados C
    FDA Consum; 2003; 37(4):29-33. PubMed ID: 12971346
    [No Abstract]   [Full Text] [Related]  

  • 33. FDA attempting to overcome major roadblocks in monitoring drug safety.
    Zielinski SL
    J Natl Cancer Inst; 2005 Jun; 97(12):872-3. PubMed ID: 15956645
    [No Abstract]   [Full Text] [Related]  

  • 34. Issues in medication safety.
    Schwarz LR
    Am J Health Syst Pharm; 2007 Jan; 64(1):21; author reply 22, 24. PubMed ID: 17189569
    [No Abstract]   [Full Text] [Related]  

  • 35. FDA regulatory compliance reconsidered.
    Tobias C
    Cornell Law Rev; 2008 Jul; 93(5):1003-38. PubMed ID: 18618969
    [No Abstract]   [Full Text] [Related]  

  • 36. The US Food and Drug Administration Modernization Act of 1997: impact on consumers.
    Golodner LF
    Clin Ther; 1998; 20 Suppl C():C20-5. PubMed ID: 9915086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recalls. FDA, industry cooperate to protect consumers.
    Nordenberg T
    FDA Consum; 1995 Oct; 29(8):24-7. PubMed ID: 10151838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dermatologic look- or sound-alike medications.
    Gremillion L; Hogan DJ
    J Drugs Dermatol; 2004; 3(1):61-4. PubMed ID: 14964748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exceptions or alternatives to labeling requirements for products held by the Strategic National Stockpile. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2012 Feb; 77(24):5696-9. PubMed ID: 22359804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescription drug safety.
    PHC4 FYI; 2004 May; (25):1-2. PubMed ID: 15168712
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.